Doyle Wealth Management Zoetis Inc. Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Zoetis Inc. stock. As of the latest transaction made, Doyle Wealth Management holds 63,191 shares of ZTS stock, worth $10.3 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

63,191

Previous 62,235 1.54%

Holding current value

$10.3 Million

Previous $10.7 Million 12.4%

% of portfolio

0.81%

Previous 0.86%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$148.29 - $182.55 $141,765 - $174,517	956 Added 1.54%	63,191 $9.37 Million
Q2 2022 Aug 10, 2022	BUY	$155.97 - $200.09 $471,497 - $604,872	3,023 Added 5.11%	62,235 $10.7 Million
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $410,666 - $529,843	2,264 Added 3.98%	59,212 $11.2 Million
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $95,489 - $121,785	493 Added 0.87%	56,948 $13.9 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $219,008 - $242,611	1,157 Added 2.09%	56,455 $11 Million
Q2 2021 Aug 03, 2021	BUY	$155.9 - $187.99 $284,205 - $342,705	1,823 Added 3.41%	55,298 $10.3 Million
Q1 2021 May 07, 2021	BUY	$144.0 - $169.39 $911,232 - $1.07 Million	6,328 Added 13.42%	53,475 $8.42 Million
Q4 2020 Feb 04, 2021	BUY	$157.07 - $174.35 $273,930 - $304,066	1,744 Added 3.84%	47,147 $7.8 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $309,983 - $373,901	2,261 Added 5.24%	45,403 $7.51 Million
Q2 2020 Aug 06, 2020	BUY	$111.92 - $142.53 $4.33 Million - $5.52 Million	38,700 Added 871.23%	43,142 $5.91 Million
Q1 2020 Apr 29, 2020	BUY	$92.66 - $144.94 $11,119 - $17,392	120 Added 2.78%	4,442 $523,000
Q4 2019 Feb 11, 2020	BUY	$116.25 - $133.25 $8,951 - $10,260	77 Added 1.81%	4,322 $572,000
Q3 2019 Nov 05, 2019	SELL	$112.57 - $128.43 $203,864 - $232,586	-1,811 Reduced 29.9%	4,245 $529,000
Q2 2019 Aug 15, 2019	BUY	$97.98 - $114.28 $391 - $457	4 Added 0.07%	6,056 $687,000
Q1 2019 May 13, 2019	SELL	$81.56 - $100.67 $107,332 - $132,481	-1,316 Reduced 17.86%	6,052 $619,000
Q4 2018 Feb 08, 2019	SELL	$79.28 - $95.27 $34,566 - $41,537	-436 Reduced 5.59%	7,368 $630,000
Q3 2018 Nov 08, 2018	SELL	$83.5 - $93.23 $135,437 - $151,219	-1,622 Reduced 17.21%	7,804 $715,000
Q2 2018 Aug 08, 2018	SELL	$79.9 - $89.2 $1.8 Million - $2.01 Million	-22,499 Reduced 70.47%	9,426 $803,000
Q1 2018 May 11, 2018	SELL	$71.51 - $84.69 $193,363 - $229,001	-2,704 Reduced 7.81%	31,925 $2.67 Million
Q4 2017 Feb 07, 2018	SELL	$63.24 - $72.8 $99,097 - $114,077	-1,567 Reduced 4.33%	34,629 $2.5 Million
Q3 2017 Oct 25, 2017	BUY	$59.73 - $65.4 $2.16 Million - $2.37 Million	36,196	36,196 $2.31 Million

Others Institutions Holding ZTS

# of Institutions

1,958

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Zoetis Inc. Transaction History